CUSTOM PROSTHETIC LTD

CUSTOM PROSTHETIC LTD specializes in the design, fabrication, and fitting of custom prosthetic devices for individuals requiring orthopedic rehabilitation support. Leveraging advanced materials science and patient-specific biomechanical modeling, the company delivers tailored lower- and upper-limb prostheses that prioritize functional mobility, comfort, and long-term durability. Their technical expertise includes 3D scanning and printing, carbon fiber composite fabrication, socket alignment optimization, and gait analysis integration, ensuring devices meet clinical standards for mobility restoration. A key differentiator is their patient-centered workflow, which combines clinician collaboration with adaptive fitting techniques to address complex anatomical variations and activity-based rehabilitation goals. While award history is not available, the company’s primary NAICS code of 621999—Other Miscellaneous Health Practitioners—indicates a focus on specialized healthcare delivery services outside traditional clinical settings, specifically in prosthetic and orthotic care. This positions CUSTOM PROSTHETIC LTD within the broader medical device and rehabilitative technology sector, serving veterans, trauma survivors, and individuals with congenital or acquired limb differences. Their operations align with federal health initiatives promoting access to high-quality, individually fitted prosthetic solutions. The entity operates as a Women-Owned Small Business (WOSB) and holds formal certification as a Woman-Owned Business, reflecting its status under federal socioeconomic programs designed to promote equitable contracting opportunities. Headquartered in Tacoma, Washington, the company maintains a localized service footprint with a focus on supporting regional healthcare networks and veterans’ care systems. Their certification and niche technical capabilities position them as a trusted provider within government-supported health and rehabilitation ecosystems, particularly where personalized medical device delivery is critical to patient outcomes.